USANA Health Sciences, Inc. (NYSE:USNA) Director Gilbert A. Fuller Sells 490 Shares

USANA Health Sciences, Inc. (NYSE:USNA) Director Gilbert A. Fuller sold 490 shares of the firm’s stock in a transaction dated Tuesday, May 7th. The stock was sold at an average price of $44.59, for a total transaction of $21,849.10. The transaction was disclosed in a document filed with the SEC, which is accessible through this link.

USANA Health Sciences Stock Performance

Shares of NYSE USNA opened at $46.32 on Friday. The business has a 50 day simple moving average of $46.38 and a 200 day simple moving average of $48.04. USANA Health Sciences, Inc. has a 52 week low of $41.45 and a 52 week high of $69.60. The stock has a market cap of $889.34 million, a price-to-earnings ratio of 14.43, a PEG ratio of 1.38 and a beta of 0.94.

USANA Health Sciences (NYSE:USNA) last posted its quarterly earnings data on Tuesday, February 6th. The company reported $0.87 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.52 by $0.35. The business had revenue of $221.08 million during the quarter, compared to the consensus estimate of $206.70 million. USANA Health Sciences had a net margin of 6.88% and a return on equity of 12.80%. On average, analysts predict that USANA Health Sciences, Inc. will post 2.75 EPS for the current year.

Institutional Investors Weigh In On USANA Health Sciences

Several hedge funds and other institutional investors have recently modified their holdings of USNA. Quest Partners LLC bought a new stake in shares of USANA Health Sciences during the fourth quarter valued at approximately $66,000. CWM LLC increased its holdings in USANA Health Sciences by 49.6% in the 4th quarter. CWM LLC now owns 1,267 shares of the company’s stock valued at $68,000 after buying an additional 420 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank raised its stake in shares of USANA Health Sciences by 60.6% in the 3rd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 3,376 shares of the company’s stock valued at $198,000 after buying an additional 1,274 shares in the last quarter. Trexquant Investment LP bought a new position in shares of USANA Health Sciences during the 4th quarter worth about $266,000. Finally, Teacher Retirement System of Texas bought a new position in shares of USANA Health Sciences during the 3rd quarter worth about $297,000. Institutional investors and hedge funds own 54.25% of the company’s stock.

Analyst Upgrades and Downgrades

USNA has been the subject of several recent analyst reports. DA Davidson decreased their target price on USANA Health Sciences from $48.00 to $46.00 and set a “neutral” rating for the company in a research note on Tuesday. StockNews.com upgraded shares of USANA Health Sciences from a “buy” rating to a “strong-buy” rating in a research report on Friday, January 12th.

About USANA Health Sciences

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.